ONCOPEPTIDES AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.91 SEK | -1.69% |
|
-18.49% | -62.01% |
| 04-15 | Oncopeptides AB Secures National Reimbursement for Pepaxti in Spain | CI |
| 04-04 | Oncopeptides AB Provides Sales Guidance for the First Quarter of 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ONCOPEPTIDES AB | Bio Therapeutic Drugs | -1.69% | -18.49% | -62.01% | -74.18% | -97.68% | 26.17M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ONCO Stock
- Charts Oncopeptides AB
- Comparison Chart
